| | | | |
Skyryse, Inc., Series B, preferred shares1,2,4 | | | | |
Laronde, Inc., Series B, 6.00% preferred shares2,4 | | | | |
Relativity Space, Inc., Series D, preferred shares2,4 | | | | |
Relativity Space, Inc., Series E, preferred shares2,4 | | | | |
PsiQuantum Corp., Series D, preferred shares2,4 | | | | |
| | | | |
QuintoAndar, Ltd., Series E-1, preferred shares2,4 | | | | |
KRY International AB, Series E1, preferred shares2,4 | | | | |
KRY International AB, Series A2,4 | | | | |
TAE Technologies, Inc., Series G2, 4.00% cumulative convertible | | | | |
| | | | |
SiFive, Inc., Series F, preferred shares2,4 | | | | |
ABL Space Systems Co., Series B, preferred shares2,4 | | | | |
ANDPAD, Inc., Series D, preferred shares2,4 | | | | |
StockX, Inc., Series E-1, preferred shares2,4 | | | | |
| | | | |
StockX, Inc., Series AA, preferred shares2,4 | | | | |
StockX, Inc., Series B, preferred shares2,4 | | | | |
Patreon, Inc., Series E, preferred shares2,4 | | | | |
Patreon, Inc., Class B2,4 | | | | |
Patreon, Inc., Series Seed, preferred shares2,4 | | | | |
Yotpo, Ltd., Series F, preferred shares2,4 | | | | |
| | | | |
Yotpo, Ltd., Series B, preferred shares2,4 | | | | |
Yotpo, Ltd., Series C, preferred shares2,4 | | | | |
Yotpo, Ltd., Series A-1, preferred shares2,4 | | | | |
Yotpo, Ltd., Series A, preferred shares2,4 | | | | |
Yotpo, Ltd., Series C-1, preferred shares2,4 | | | | |
Yotpo, Ltd., Series D, preferred shares2,4 | | | | |
Yotpo, Ltd., Series B-1, preferred shares2,4 | | | | |
WorkRise Technologies, Inc., Series E, preferred shares2,4 | | | | |
InSilico Medicine Cayman TopCo, Series D, preferred shares2,4 | | | | |
Tarana Wireless, Inc., Series 6, noncumulative convertible preferred | | | | |
| | | | |
Bluestar Genomics, Inc., Series C, 5.00% noncumulative preferred | | | | |
Bluestar Genomics, Inc., convertible notes, 8.00% 10/28/20251,4 | | | | |
Kandou Holding SA, Series D, preferred shares2,4 | | | | |
RealSelf, Inc., Series C, convertible preferred shares1,4 | | | | |
Artiva Biotherapeutics, Inc., Series B, preferred shares2,4 | | | | |
Foursquare Labs, Inc., Series A2,4 | | | | |
Foursquare Labs, Inc., Series A, warrants, expire 12/4/20332,4 | | | | |
PACT Pharma, Inc., Series C, 8.00% noncumulative preferred | | | | |
| | | | |